Literature DB >> 26501631

Incorporation of MRI-AIF information for improved kinetic modelling of dynamic PET data.

Hasan Sari1, Kjell Erlandsson1, Kris Thielemans1, David Atkinson2, Simon Arridge3, Sebastien Ourselin3, Brian Hutton1.   

Abstract

Entities:  

Year:  2014        PMID: 26501631      PMCID: PMC4545800          DOI: 10.1186/2197-7364-1-S1-A43

Source DB:  PubMed          Journal:  EJNMMI Phys        ISSN: 2197-7364


× No keyword cloud information.
Pharmacokinetic analysis of dynamic PET data requires estimation of the arterial input function (AIF). An alternative method to collecting blood samples during scanning is the simultaneous estimation approach in which AIF and kinetic parameters are estimated at once [1]. We have investigated how information from a simultaneous MRI-AIF can be incorporated into this model and evaluated its effect on estimated kinetic parameters by comparing absolute bias and coefficient of variation (CV) values on influx constants (Ki). As the delivery of the tracer or contrast agent is dominated by vascular flow dynamics, PET-AIF and MRI-AIF boluses will have similar peak shapes if the same injection speed is used [2, 3]. Hence it can be assumed that the values of λ1 of eq. 1 [1] can be fixed to reduce the number of parameters in fitting. Simulated data was generated using two tissue compartment model with rate constants from a clinical brain study [5]. Noise was added using eq. 2 where α set to 0.5,2 and 4. AIF scaling was done using one blood sample obtained at the end of the study, or by fixing A3 and λ3 to their true values assuming they can be determined using multiple blood samples. As shown in Figure 1 and 2, when λ1 is fixed, larger improvements (from 13.84% to 5.38%, averaged on all noise levels) were seen on the bias of estimates with one blood sample compared to the method with multiple samples (from 13.54% to 10.60%). For CV, improvement was slightly higher on scaling with multiple samples when λ1 was fixed.
Figure 1

Percentage absolute bias on Ki estimates, averaged over three ROIs, when noise level was set to (a) 0.5, (b) 2, (c) 4. Blue bars show the bias with the scaling method with one blood sample at the end of the study, green bars show the bias with the scaling method where the tail is fit to the multiple blood samples towards the end of study and red bars show the bias which would be present when all six parameters of the AIF was set to their true values.

Figure 2

Coefficient of variation values over 50 Ki estimates, averaged over three ROIs, when noise level was set to (a) 0.5, (b) 2, (c) 4. Blue bars show the CV with the scaling method with one blood sample at the end of the study, green bars show the CV with the scaling method where the tail is fit to the multiple blood samples towards the end of study and red bars show the CV which would be present when all six parameters of the AIF was set to their true values.

Percentage absolute bias on Ki estimates, averaged over three ROIs, when noise level was set to (a) 0.5, (b) 2, (c) 4. Blue bars show the bias with the scaling method with one blood sample at the end of the study, green bars show the bias with the scaling method where the tail is fit to the multiple blood samples towards the end of study and red bars show the bias which would be present when all six parameters of the AIF was set to their true values. Coefficient of variation values over 50 Ki estimates, averaged over three ROIs, when noise level was set to (a) 0.5, (b) 2, (c) 4. Blue bars show the CV with the scaling method with one blood sample at the end of the study, green bars show the CV with the scaling method where the tail is fit to the multiple blood samples towards the end of study and red bars show the CV which would be present when all six parameters of the AIF was set to their true values. We have shown that information from simultaneous MRI-AIF can reduce the bias on Ki estimates and multiple blood samples might not be necessary, as the scaling method with one blood sample performed better when a parameter reflecting the early part of the MRI-AIF is included.
  4 in total

1.  COMKAT: compartment model kinetic analysis tool.

Authors:  R F Muzic; S Cornelius
Journal:  J Nucl Med       Date:  2001-04       Impact factor: 10.057

2.  A technique for extracting physiological parameters and the required input function simultaneously from PET image measurements: theory and simulation study.

Authors:  D Feng; K P Wong; C M Wu; W C Siu
Journal:  IEEE Trans Inf Technol Biomed       Date:  1997-12

3.  Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumors with PET.

Authors:  R A Hawkins; M E Phelps; S C Huang
Journal:  J Cereb Blood Flow Metab       Date:  1986-04       Impact factor: 6.200

4.  Conversion of arterial input functions for dual pharmacokinetic modeling using Gd-DTPA/MRI and 18F-FDG/PET.

Authors:  Eric Poulin; Réjean Lebel; Etienne Croteau; Marie Blanchette; Luc Tremblay; Roger Lecomte; M'hamed Bentourkia; Martin Lepage
Journal:  Magn Reson Med       Date:  2012-05-08       Impact factor: 4.668

  4 in total
  3 in total

Review 1.  Potential of PET-MRI for imaging of non-oncologic musculoskeletal disease.

Authors:  Feliks Kogan; Audrey P Fan; Garry E Gold
Journal:  Quant Imaging Med Surg       Date:  2016-12

2.  Perfusion weighted imaging using combined gradient/spin echo EPIK: Brain tumour applications in hybrid MR-PET.

Authors:  N Jon Shah; Nuno André da Silva; Seong Dae Yun
Journal:  Hum Brain Mapp       Date:  2019-02-13       Impact factor: 5.038

3.  Non-invasive kinetic modelling of PET tracers with radiometabolites using a constrained simultaneous estimation method: evaluation with 11C-SB201745.

Authors:  Hasan Sari; Kjell Erlandsson; Lisbeth Marner; Ian Law; Henrik B W Larsson; Kris Thielemans; Sébastien Ourselin; Simon Arridge; David Atkinson; Brian F Hutton
Journal:  EJNMMI Res       Date:  2018-07-03       Impact factor: 3.138

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.